They are also evaluating another combination therapy through their partnership, looking at the efficacy of Tyvyt with surufatinib, a novel inhibitor of VEGFR, fibroblast growth factor receptor 1 ...
For millions of people, losing muscle isn't just about weakness; it's about losing independence. Whether caused by Duchenne ...
The Arkansas Integrative Metabolic Research Center will explore the potential of a novel, artificially designed, hybrid growth factor to regulate the metabolism of fat and cancer cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback